Picture of Novakand Pharma AB logo

NOVKAN — Novakand Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Kancera Q2 Operating Loss Widens To SEK 12.7 Million

Aug 23 (Reuters) - Kancera AB  KANC.ST :
    * Q2 OPERATING LOSS SEK 12.7 MILLION VERSUS LOSS SEK 10.2
MILLION
YEAR AGO

Source text for Eikon:  ID:nWkr8P2pVx 
Further company coverage:  KANC.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Novakand Pharma AB

See all news